Safety evaluation of bi‐layered allogenic keratinocyte and fibroblast skin substitute for diabetic foot ulcers— <scp>SAFESKIN</scp> ‐ <scp>DFU</scp> : A Phase <scp>1</scp> clinical trial
The application of a bi-layered allogeneic keratinocyte and fibroblast skin substitute in patients with chronic DFU was safe and associated with favourable wound healing results. Adherence to standard treatment protocols, including optimal offloading, is essential to maximize the likelihood of successful wound healing.
Authors
- Nader Fallah (ORCID: https://orcid.org/0000-0002-7746-4773)
- Ensiyeh Hajizadeh‐Saffar
- Zahra Khalajasadi
- Hoda Madani (ORCID: https://orcid.org/0000-0002-0720-0887)
- Azam Samadian (ORCID: https://orcid.org/0009-0000-5850-2300)
- Seyedeh‐Nafiseh Hassani (ORCID: https://orcid.org/0000-0001-5047-8406)
- Bahareh Sadri (ORCID: https://orcid.org/0000-0002-1375-1052)
- Raheleh Aghdami
- Shayan Farzanbakhsh (ORCID: https://orcid.org/0009-0007-7419-9402)
- Hossein Baharvand (ORCID: https://orcid.org/0000-0001-6528-3687)
- Mohammad Reza Amini (ORCID: https://orcid.org/0000-0002-5550-6792)
- Massoud Vosough (ORCID: https://orcid.org/0000-0001-5924-4366)
Institutions
- Royan Institute (IR)
- Academic Center for Education, Culture and Research (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1111/dom.15843
- Citations
- 2
- Primary Topic
- Diabetic Foot Ulcer Assessment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.72